ST14 Antikörper (N-Term)
-
- Target Alle ST14 Antikörper anzeigen
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ST14 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody reacts to the N-term of Suppression Of Tumorigenicity 14 (colon Carcinoma, Matriptase, Epithin) (ST14).
- Aufreinigung
- Immunoaffinity Chromatography
- Immunogen
- ST14 antibody was raised against synthetic peptide - KLH conjugated Genename: ST14
- Isotyp
- IgG
- Top Product
- Discover our top product ST14 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1,0 mg/mL
- Buffer
- PBS (without Mg2+, Ca2+), pH 7.4 containing 150 mM sodium chloride, 0.02 % sodium azide as preservative and 50 % glycerol as stabilizer
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- -20 °C
-
- Target
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
- Andere Bezeichnung
- ST14 / Matriptase (ST14 Produkte)
- Hintergrund
- Synonyms: Membrane-type serine protease 1, PRSS14, Prostamin, SNC19, Serine protease 14, Serine protease TADG-15, Suppressor of tumorigenicity 14 protein, T-SP1, TADG15, Tumor-associated differentially-expressed gene 15 protein
- Gen-ID
- 6768
- NCBI Accession
- NP_068813
- UniProt
- Q9Y5Y6
-